iCHOR Vascular Inc

One size fits all solution for peripheral clot removal (DVT & PAD) without the need for drugs or surgical intervention.

  • Stage Product In Market
  • Industry Medical Devices and Equipment
  • Location Minneapolis, MN, USA
  • Currency USD
  • Founded November 2014
  • Employees 3
  • Incorporation Type C-corp
  • Website ichorvascular.com

Company Summary

ICHOR Vascular has 510(k) market clearance for a 7F Percutaneous Arterial Reperfusion System (clot removal)! The 14F System is optimized for venous thrombosis and was recently 510(k) cleared in September 2023. ICHOR aims to be the future in treating a wide range of vascular occlusions by offering a singular product with broad utility.

Team

Advisors

  • Mike Cohn, MD
    Unconfirmed
    Troy Long Md
    Unconfirmed
    George Adams, Md (UNC)
    Unconfirmed
  • Ken Ouriel, MD
    Unconfirmed

Previous Investors

  • Cleveland Clinic (GCIC)
    Unconfirmed
    OSF (Peoria, IL)
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free